FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Department of Medicine 4 – Nephrology and Hypertension
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Overview
Publications
(1,181)
Research Grants
(11)
Project Types
Toggle all
Third Party Funds Group - Overall project
Third Party Funds Group - Overall project
Third Party Funds Group - Sub project
Third Party Funds Group - Sub project
Third party funded individual grant
Third party funded individual grant
Internally funded project
Internally funded project
FAU own research funding: EFI / IZKF / EAM ...
FAU own research funding: EFI / IZKF / EAM ...
Non-FAU Project
Non-FAU Project
Status
All
Upcoming
Ongoing
Finished
Project year
From
To
Filters (inactive)
Glomerular-specific targeting with functionalized drug loaded nanoparticles for precision medicine in glomerular diseases
June 1, 2024 - May 31, 2027
P149: Podocyte specific targeting with functionalized drug loaded nanoparticles for precision medicine
Aug. 1, 2024 - Jan. 31, 2027
J098: Systematic identification and characterization of disease genes for urorectal Malformations
Jan. 1, 2023 - June 30, 2025
P148: Differential modulation of Wnt/beta-catenin signaling in kidney disease
March 1, 2024 - Dec. 31, 2024
Genetic and pathophysiology of rare kidney diseases
March 1, 2023 - Feb. 29, 2024
F009: Generation of novel 3D co-culture systems for study of glomerular functions ex vivo
June 16, 2020 - June 15, 2023
D035: Linking a renal cancer associated SNP in the chromatin remodeller DPF3 with hypoxia signalling
July 1, 2020 - Dec. 31, 2022
P108: Glomerular cell-derived exosome characterization and nanoparticles as therapeutic option in renal disease
May 1, 2022 - Oct. 31, 2022
IZKF-J70 (M4): From gene to function: a translational pipeline for gene discovery and allele testing in kidney disease
Oct. 1, 2018 - Sept. 30, 2021
IZKF-J71 (M4): Inhibition of the purinergic receptor P2Y2R as a potential therapeutic intervention in ADPKD
Jan. 1, 2019 - June 30, 2021
‹
1
2
›